GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT : Impact Factor & More
eISSN: 2283-5733pISSN: 2284-2403
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT
GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT Journal Specifications
Indexed in the following public directories
Web of Science 
DOAJ
| Overview | |
| Publisher | ABOUTSCIENCE SRL |
| Language | English,Italian,Spanish |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 1500 |
| Publication Time | 8 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English,Italian,Spanish |
| Frequency | Continuous publication |
| Publication Start Year | 2014 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT
Advanced-Metastatic Non-Small-Cell Lung Cancer EGFR-mutated in Italy: patient management costs and potential productivity losses
- 1 Jan 2019
- Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish
Cost per response/remission in biologics available in Italy for the treatment of TNF-α inhibitors-naïve patients with ulcerative colitis
- 1 Jan 2019
- Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish
The economic impact of biosimilars in Italy: a scenario analysis
- 1 Jan 2019
- Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish
Early Access in Oncology: Why Is It Needed?
- 1 Jan 2019
- Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish
Cost-effectiveness analysis of alectinib versus crizotinib in first-line treatment of anaplastic lymphoma kinase-positive advanced non-small cell lung cancer
- 1 Jan 2019
- Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish
Management of patients eligible for proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: economic impact and reform proposals
- 1 Jan 2019
- Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish
Advanced-Metastatic Non-Small-Cell Lung Cancer EGFR-mutated in Italy: patient management costs and potential productivity losses
- 1 Jan 2019
- Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish
Cost per response/remission in biologics available in Italy for the treatment of TNF-α inhibitors-naïve patients with ulcerative colitis
- 1 Jan 2019
- Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish
The economic impact of biosimilars in Italy: a scenario analysis
- 1 Jan 2019
- Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish
Early Access in Oncology: Why Is It Needed?
- 1 Jan 2019
- Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish
Cost-effectiveness analysis of alectinib versus crizotinib in first-line treatment of anaplastic lymphoma kinase-positive advanced non-small cell lung cancer
- 1 Jan 2019
- Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish
Management of patients eligible for proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: economic impact and reform proposals
- 1 Jan 2019
- Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish
FAQs on GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT
How long has GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT been actively publishing? 
What is the publishing frequency of GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT?
How many articles did GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT publish last year?
What is the eISSN & pISSN for GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT?
Who is the publisher of GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT?
